This inventor holds 2 USPTO granted patents. Top assignee: Alembic Limited. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gujarat, IN (2007)
- Vadodara, IN (2007)
Company Filing History:
Years Active: 2007
Title: Vinod Kumar Kansal: Innovator in Pharmaceutical Processes
Introduction
Vinod Kumar Kansal is a notable inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug preparation. With a total of 2 patents to his name, his work has the potential to impact the efficiency and cost-effectiveness of pharmaceutical manufacturing.
Latest Patents
Kansal's latest patents include a process for the preparation of azithromycin monohydrate isopropanol clathrate. This invention presents an improved, cost-effective, and straightforward method for synthesizing azithromycin monohydrate isopropanol clathrate directly from 9-deoxo-9a-aza-9a-homoerythromycin A. The process involves dissolving or suspending the starting material in isopropanol, followed by the addition of a methylating solution, heating, and adjusting the pH to isolate pure azithromycin monohydrate isopropanol clathrate. This method not only reduces preparation time but also minimizes production costs and handling losses.
Another significant patent by Kansal is the process for the preparation of 2-[(diphenylmethyl)thio]acetamide, which serves as an intermediate for Modafinil, a CNS stimulant used in treating narcolepsy. This process entails reacting 2-[(diphenylmethyl)thio]acetic acid with alcohols in the presence of an acid catalyst, followed by a reaction with ammonia to yield the desired compound. The resulting 2-[(diphenylmethyl)thio]acetamide can further be converted into Modafinil using hydrogen peroxide.
Career Highlights
Vinod Kumar Kansal is currently associated with Alembic Limited, a prominent pharmaceutical company. His work at Alembic has allowed him to focus on innovative drug development processes that enhance the efficiency of pharmaceutical production.
Collaborations
Kansal has collaborated with notable colleagues such as Dhiren Natavarlal Mistry and Mahadeo Maroti Thorat. These collaborations have contributed to the advancement of pharmaceutical innovations within their organization.
Conclusion
Vinod Kumar Kansal's contributions to pharmaceutical processes exemplify the importance of innovation in drug development. His patents not only enhance
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile